Section 4: Clinical Pharmacy Services 2020
DOI: 10.1136/ejhpharm-2020-eahpconf.251
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-150 Assessment of burden of disease in terms of health related quality of life in patients with multiple myeloma not eligible for autologous stem cell transplantation

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles